Resources

GLP-1 Use Is Growing, but Adoption Is Uneven

New insights from Evidation explore who remains outside GLP-1 treatment and how cost, coverage, information, and real-world experience may shape access.

Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market

Among 119,000 surveyed individuals actively trying to lose weight, 24% had ever used prescription medication for weight management and 15% had ever used a GLP-1, suggesting significant room for continued market growth as adoption varies by age, gender, and income.

ISPOR 2026 Recap: Understanding Health Between Visits

Evidation’s research at ISPOR 2026 highlighted the growing need for direct, longitudinal patient data to better understand real-world outcomes

Creating a Complete View of Dermatology Care to Strengthen Brand and Portfolio Decisions to Drive Competitive Advantage

Explore how longitudinal, multimodal real-world data collected through direct connections to individuals can sharpen brand positioning, clarify unmet need, and strengthen lifecycle and access strategy in competitive dermatology markets.

Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights

New cohort is designed to address gaps in understanding treatment journeys across the full continuum of care. Insights show that consumer health products play a critical part in how individuals understand and manage their skin conditions.

Enabling Next-Generation AI in Autoimmune R&D

Explore how longitudinal, temporally relevant, multimodal data collected through direct connections with individuals can help unlock new opportunities across early R&D for immune-mediated diseases.

Building with Patients: A Conversation with Rachel Sha, CEO of Vaxess Technologies

Vaxess Technologies CEO Rachel Sha shares how patient voices are driving new delivery solutions for anti-obesity medications, with the potential to dramatically expand access and improve adherence.

Evidation partners with 1upHealth to integrate diverse sources of permissioned real-world health data for research

Evidation and 1upHealth announce a long-term partnership to advance patient-centered, real-world health research.

Better data, better outcomes: Weight management

Survey + wearable data from Evidation members about their weight management experiences have highlighted real-world priorities, challenges, and opportunities in this space. Watch our Lunch & Learn to learn more.

REVEAL, a prospective, observational study

Evidation and partners aimed to examine the impact of paroxysmal nocturnal hemoglobinuria (PNH) and its treatment on patients’ daily lives by combining patient-reported outcomes with wearable technology.

Elizabeth A. Griffiths, Jae S. Min, Wei-Nchih Lee, Jeffrey C. Yu, Yogesh Patel, Karl-Johan Myren, & David Dingli